Effects of Lipid Elimination and Liver Benefit formula combined with selegiline on liver function and blood lipid level in patients with non-alcoholic fatty liver disease
Objective:To analyze the effect of Lipid Elimination and Liver Benefit formula combined with selegiline on liver function and blood lipid level in patients with non-alcoholic fatty liver disease.Methods:A total of 82 patients with non-alcoholic fatty liver who were treated in our hospital from January 2020 to December 2021 were selected as the research subjects.They were randomly divided into a control group of 40 cases and a study group of 42 cases using a random number table method.The control group was treated with Sigliptin,while the study group was treated with Xiaozhi Yigan Formula combined with Sigliptin.Detect blood lipid levels,insulin function,liver function,inflammatory indicators,and clinical efficacy of each group of patients.Results:Compared with before treatment,TC,LDL-C,ALT,ALP,AST,GGT,IL-6,TNF in both groups of patients after treatment-α,CRP,FINS,HOMA-IR levels decrease,HOMA-β F.The HDL-C level increased,and the study group was lower/higher than the control group(P<0.05).Compared with the control group,the clinical efficacy of the study group was higher(P<0.05).Conclusion:The combination of Xiaozhi Yigan Formula and Xigliptin treatment can improve liver function and lower blood lipid levels in patients with non-alcoholic fatty liver disease and has a good clinical effect.
non alcoholic fatty liver diseaseXiaozhi Yigan formulaSiagliptinliver function
NETL
NSTL
万方数据
维普
